drugset / Trial / NCT00338754

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00338754

Phase 2/3 Completed 160 enrolled Abbott Eisai Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the efficacy and safety of repeated administration of adalimumab in adult Japanese subjects with moderate to severe chronic plaque psoriasis.

Timeline

Start
2005-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Adalimumab Monoclonal antibody

Indications